Mankind Pharma

Please find attached Intimation regarding withdrawal and outstanding Credit Ratings granted by ICRA Limited

16 Jan, 2026 | 06:27pm • Source: BSE

Please find attached intimation regarding Investor Conference Call for Q3 & 9M FY26 with Senior Management

16 Jan, 2026 | 03:22pm • Source: BSE

Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and...

09 Jan, 2026 | 11:53am • Source: BSE

Please find attached Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025.

05 Jan, 2026 | 04:06pm • Source: BSE

Please find attached, intimation regarding Closure of the Trading Window

24 Dec, 2025 | 01:34pm • Source: BSE

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)

10 Dec, 2025 | 06:27pm • Source: BSE

Mankind Pharma Limited has informed the Exchange about General Updates

10 Dec, 2025 | 01:54pm • Source: NSE

Please find attached intimation regard ESG rating

10 Dec, 2025 | 01:47pm • Source: BSE

Please find attached intimation regarding ESG Rating assigned by SES ESG Research Private Limited.

28 Nov, 2025 | 04:38pm • Source: BSE

Please find attached Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

16 Nov, 2025 | 03:13pm • Source: BSE

Mankind Pharma Limited has informed the Exchange about Schedule of meet

13 Nov, 2025 | 12:56pm • Source: NSE

Please find enclosed herewith transcript of the investor Conference Call for Q2 & H1 FY 26

11 Nov, 2025 | 05:49pm • Source: BSE

Please find attached intimation for participation in the Investor Conference.

07 Nov, 2025 | 03:02pm • Source: BSE

Please find attached intimation regarding newspaper advertisement-unaudited financial results of the Company for Q2H1FY26.

07 Nov, 2025 | 11:46am • Source: BSE

Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q2H1FY26

06 Nov, 2025 | 08:00pm • Source: BSE

Financial Results for the quarter and half year ended 30th September 2025

06 Nov, 2025 | 04:38pm • Source: BSE

Press Release for Q2FY26

06 Nov, 2025 | 04:32pm • Source: BSE

Investor Presentation for Q2FY26

06 Nov, 2025 | 04:30pm • Source: BSE

Un-audited Financial Results for the Quarter and Half Year ended 30.09.2025

06 Nov, 2025 | 04:29pm • Source: BSE

Please find attached ESG Rating

29 Oct, 2025 | 10:16pm • Source: BSE